Glenmark Pharmaceuticals Ltd. - Research Center

---

	Mar ' 09	Mar ' 08	Mar ' 07	Mar ' 06	Mar ' 05
Sources of funds
Owner's fund
Equity share capital	25.05	24.87	24.01	23.74	23.72
Share application money	-	-	-	-	-
Preference share capital	-	-	-	20.00	20.00
Reserves & surplus	1,204.92	1,003.38	426.15	275.01	242.98
Loan funds
Secured loans	112.21	191.33	170.03	141.83	129.30
Unsecured loans	949.14	333.22	737.45	586.21	307.43
Total	2,291.32	1,552.79	1,357.64	1,046.80	723.44
Uses of funds
Fixed assets
Gross block	270.48	483.74	364.66	318.96	258.62
Less : revaluation reserve	-	-	-	-	-
Less : accumulated depreciation	97.67	116.20	87.74	66.40	49.32
Net block	172.81	367.53	276.91	252.57	209.30
Capital work-in-progress	32.45	225.57	156.30	57.56	12.91
Investments	237.63	196.70	139.10	43.56	26.46
Net current assets
Current assets, loans & advances	2,133.31	1,145.56	1,052.89	854.24	592.16
Less : current liabilities & provisions	284.87	382.57	267.55	161.13	117.38
Total net current assets	1,848.44	762.99	785.34	693.11	474.78
Miscellaneous expenses not written	-	-	-	-	-
Total	2,291.32	1,552.79	1,357.64	1,046.80	723.44
Notes:
Book value of unquoted investments	237.59	196.66	139.05	43.52	26.41
Market value of quoted investments	0.20	0.24	0.16	0.13	0.10
Contingent liabilities	965.00	587.54	131.23	4.82	0.46
Number of equity sharesoutstanding (Lacs)	2505.20	2487.26	1200.58	1187.21	1186.21

© Copyright 2009 Rediff.com India Limited. All rights reserved. DisclaimerTerms of ServicePrivacy PolicyFeedback